Table 1.
Clinical features of the patients
| Features |
Total(n) |
p value |
| Gender | ||
| Male | 62 | 0.613 |
| Female | 57 | |
| Age (years) | ||
| ≥60 | 39 | 0.592 |
| <60 | 80 | |
| T Stages | ||
| I–II | 75 | <0.001 |
| III–IV | 44 | |
| Metastasis | ||
| N Stages | ||
| N0 | 59 | <0.001 |
| N1-2 | 60 | |
| M Stages | ||
| M0 | 72 | <0.001 |
| M1 | 47 |
Clinical features of the patients
| Features |
Total(n) |
p value |
| Gender | ||
| Male | 62 | 0.613 |
| Female | 57 | |
| Age (years) | ||
| ≥60 | 39 | 0.592 |
| <60 | 80 | |
| T Stages | ||
| I–II | 75 | <0.001 |
| III–IV | 44 | |
| Metastasis | ||
| N Stages | ||
| N0 | 59 | <0.001 |
| N1-2 | 60 | |
| M Stages | ||
| M0 | 72 | <0.001 |
| M1 | 47 |